Condition
Left Atrial Appendage
Total Trials
6
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Unknown3
Withdrawn1
Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT05951101Not ApplicableRecruiting
Zenith LAA Occlusion System
NCT01786486Completed
AMPLATZER Cardiac Plug (ACP) Registry-Long Term Follow-up Protocol
NCT04897204Not ApplicableUnknown
Left Atrial Appendage Electrical Isolation in Persistent Atrial Fibrillation
NCT01962051Withdrawn
AMPLATZER Cardiac Plug (ACP) Latin American Post Market Observational
NCT03133806Not ApplicableUnknownPrimary
Canadian Left Atrial Appendage Closure Study
NCT01522911Not ApplicableUnknown
Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage
Showing all 6 trials